What is EuroEyes International Eye Clinic FCF Margin %?
EuroEyes International Eye ClinicHKSE:01846 84 FCF Margin % is 18.58% as of Dec. 2025, which is 21% above its 10-year median of 15.37. GuruFocus rates HKSE:01846 with a GF Score™ of 84/100 and a GF Value™ of HK$5.52 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 665 Healthcare Providers & Services companies, EuroEyes International Eye Clinic ranks better than 91.28% on this metric.
The historical rank and industry rank for EuroEyes International Eye Clinic's FCF Margin % or its related term are showing as below:
HKSE:01846'
s FCF Margin % Range Over the Past 10 Years
Min: -6.08 Med: 15.37 Max: 36.13
Current: 18.61
During the past 10 years, the highest FCF Margin % of EuroEyes International Eye Clinic was 36.13%. The lowest was -6.08%. And the median was 15.37%.
HKSE:01846's FCF Margin % is ranked better than 91.28% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 3.1
vs HKSE:01846: 18.61
EuroEyes International Eye Clinic FCF Margin % Related Terms
EuroEyes International Eye Clinic FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EuroEyes International Eye Clinic FCF Margin % Chart
HKSE:01846 vs HCA, THC, DVA: FCF Margin % Comparison
For the Medical Care Facilities subindustry, EuroEyes International Eye Clinic's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EuroEyes International Eye Clinic FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EuroEyes International Eye Clinic's FCF Margin % distribution charts can be found below:
* The bar in red indicates where EuroEyes International Eye Clinic's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EuroEyes International Eye Clinic (HKSE:01846) has a FCF Margin % of 18.58% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on EuroEyes International Eye Clinic and its competitors. This is 21% above median its historical median of 15.37. According to the industry distribution chart, EuroEyes International Eye Clinic ranks #58 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 8.7%.
Is EuroEyes International Eye Clinic's FCF Margin % too high?
EuroEyes International Eye Clinic's current FCF Margin % of 18.58% is 21% above median its 10-year median of 15.37. The Healthcare Providers & Services industry median FCF Margin % is 3.10. EuroEyes International Eye Clinic's value of 18.58% is 499.4% above this industry median. Based on the distribution chart, EuroEyes International Eye Clinic ranks #58 out of 665 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, EuroEyes International Eye Clinic has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EuroEyes International Eye Clinic's FCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, EuroEyes International Eye Clinic ranks #58 out of 665 companies for FCF Margin %. This places EuroEyes International Eye Clinic in the top 9% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 3.10. EuroEyes International Eye Clinic's value of 18.58% is 499.4% above this benchmark. While the company's 10-year median is 15.37 vs. the industry median of 3.10, EuroEyes International Eye Clinic has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.10, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EuroEyes International Eye Clinic's current FCF Margin % of 18.58% is 499.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on EuroEyes International Eye Clinic and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EuroEyes International Eye Clinic's current FCF Margin % is 18.58%, which is 21% above median its own 10-year median of 15.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EuroEyes International Eye Clinic stock overvalued right now?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic (HKSE:01846) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$5.52, compared to a current price of HK$2.40 — trading 56.5% below its estimated fair value. The current FCF Margin % is 18.58%, which is 21% above median its 10-year median of 15.37 and 499.4% above the Healthcare Providers & Services industry median of 3.10. EuroEyes International Eye Clinic's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For EuroEyes International Eye Clinic (HKSE:01846), the current FCF Margin % is 18.58% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EuroEyes International Eye Clinic (HKSE:01846) Overvalued in 2026?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic stock appears to be undervalued.
The current stock price of HK$2.40 is trading 56.5% below its estimated GF Value™ of HK$5.52.
GuruFocus considers EuroEyes International Eye Clinic to be Significantly Undervalued.
Key valuation signals for HKSE:01846:
FCF Margin %: 18.58% (21% above median its 10-year median of 15.37)
GF Value™: HK$5.52 vs. price of HK$2.40 (56.5% below fair value)
Industry Position: 499.4% above the Healthcare Providers & Services median (#58 of 665)
No single metric tells the full story. See the HKSE:01846 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EuroEyes International Eye Clinic Business Description
EuroEyes International Eye Clinic Ltd is principally engaged in the provision of vision correction services in Germany, Denmark, the UK, the PRC including Hong Kong, and Switzerland. The Group is a high-end vision correction service provider in Germany, PRC, the UK, Denmark, and Switzerland. Its vision correction services include refractive laser surgery, phakic lens surgery (ICL), lens exchange surgery, and others including PRK/LASEK and ICRS implantation. Its revenue categories include provision of vision correction services generate maximum revenue, training services, sales of pharmaceutical products and others. The Group's five reportable segments are Germany generate maximum revenue, Denmark, UK, Chinese Mainland, and Switzerland.
84GF Score
Get the complete analysis for HKSE:01846
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01846 has been successfully added to your 
